Two Drugs Get EU OK for Rare Neonatal Diabetes and Still ' s Disease Two Drugs Get EU OK for Rare Neonatal Diabetes and Still ' s Disease

Two medications for rare conditions have been given the thumbs up by the CHMP: an oral suspension of the sulfonylurea glibenclamide for neonatal diabetes in children and anakinra for Still ' s disease.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news